Skip to content

Encore Rheumatoid Factor Eia

by Clark Laboratories, Inc.

510(k) K924056

Encore Rheumatoid Factor Eia is a medical device (FDA Class II; FDA product code DHR, System, Test, Rheumatoid Factor) made by Clark Laboratories, Inc., cleared under FDA 510(k) K924056 on 25 Sep 1992, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK924056 Date25 Sep 1992ClearedStatusActive

Official records

From the FDA record

Received by the FDA
12 Aug 1992
FDA decision
25 Sep 1992 (Substantially Equivalent)
FDA review time
44 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K924056 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
DHR
Device class
Class II
Regulation
21 CFR Part 866.5775
Advisory committee
Immunology
FDA decision
SESE Substantially Equivalent

Devices cleared under K924056

1 device · FDA GUDID

Devices that FDA's GUDID lists as cleared or approved under this submission number. One submission usually covers a whole product family, so the sizes and models are listed here once.

Devices cleared under K924056
UDI-DISize and differences
Trinity Biotech 2328250
CLARK LABORATORIES, INC.
2328250 / 232825005391516747158 —On the market

Similar devices

Other devices filed under FDA product code DHR (System, Test, Rheumatoid Factor).

Other devices from Clark Laboratories, Inc.

See all devices from Clark Laboratories, Inc. →